As COVID-19 surges in the United States and around the world, health officials are responding with stern...
Q120 remained a bright spot showing positive growth with modest disruption from COVID-19 for the quarter...
The US market for Hemostats and Sealants grew +6.1% YoY in Q120, up from the pace of Q419 despite the la...
The SCS market saw double-digit declines in Q120 as elective procedures fell off a cliff toward the end ...
As the international response to COVID-19 shifts to preparing for a potential second wave, the Medtech i...
COVID-19 halts the Trauma Market’s Q120 growth, leading to a -2.8% YoY decline globally. Q120 was tracki...
This week, our expert analysts have sifted through the noise to present some of the latest product devel...
In Q120, the US and EU AWC markets experienced modest gains, offset by ROW (China) hit early in the quar...
Spine’s solid start to Q120 was derailed in March by COVID-19, leading to a -10.6% YoY decline globally....
As states begin to loosen restrictions and we try and put COVID-19 in the rear view mirror, in the words...